Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lifecore seeks US approval for anti-adhesion gel:

This article was originally published in Clinica

Executive Summary

Lifecore Biomedical has filed a premarket approval application with the FDA for its Intergel solution for preventing post-operative adhesions. The fifth and final module of the application, submitted earlier this month, contains an analysis of data from a clinical trial of the ferric hyaluronate product involving over 265 women who underwent intraperitoneal laparotomy procedures, said the Chaska, Minnesota-based company. The product is currently marketed in Europe by the Gynecare Division of Ethicon, a Johnson & Johnson company.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT077788

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel